Hörl WH - Search Results

1

Effect of erythropoietin on cardiovascular diseases.

Sunder-Plassmann G, Hörl WH. Sunder-Plassmann G, et al. Among authors: horl wh. Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S20-5. doi: 10.1053/ajkd.2001.27391. Am J Kidney Dis. 2001. PMID: 11576916 Review.

2

Contribution of anaemia to progression of renal disease: a debate.

Rossert JA, McClellan WM, Roger SD, Verbeelen DL, Hörl WH. Rossert JA, et al. Among authors: horl wh. Nephrol Dial Transplant. 2002;17 Suppl 1:60-6. doi: 10.1093/ndt/17.suppl_1.60. Nephrol Dial Transplant. 2002. PMID: 11812915 Review.

3

Novel aspects of erythropoietin response in renal failure patients.

Sunder-Plassmann G, Hörl WH. Sunder-Plassmann G, et al. Among authors: horl wh. Nephrol Dial Transplant. 2001;16 Suppl 5:40-4. doi: 10.1093/ndt/16.suppl_5.40. Nephrol Dial Transplant. 2001. PMID: 11509683 Review.

4

The dilemma of evaluating iron status in dialysis patients--limitations of available diagnostic procedures.

Sunder-Plassmann G, Spitzauer S, Hörl WH. Sunder-Plassmann G, et al. Among authors: horl wh. Nephrol Dial Transplant. 1997 Aug;12(8):1575-80. doi: 10.1093/ndt/12.8.1575. Nephrol Dial Transplant. 1997. PMID: 9269632 No abstract available.

5

Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.

Födinger M, Mannhalter C, Pabinger I, Koizar D, Rintelen C, Hörl WH, Sunder-Plassmann G. Födinger M, et al. Among authors: horl wh. Nephrol Dial Transplant. 1996 Apr;11(4):668-72. doi: 10.1093/oxfordjournals.ndt.a027357. Nephrol Dial Transplant. 1996. PMID: 8671856

6

Cardiovascular effects of increasing hemoglobin in chronic renal failure.

Mayer G, Hörl WH. Mayer G, et al. Among authors: horl wh. Am J Nephrol. 1996;16(4):263-7. doi: 10.1159/000169007. Am J Nephrol. 1996. PMID: 8739276 Review.

7

[Cardiovascular operations in patients with perioperative reduced kidney function].

Fraedrich G, Buob R, Hörl W, Schlosser V. Fraedrich G, et al. Langenbecks Arch Chir. 1987;372:619-21. doi: 10.1007/BF01297896. Langenbecks Arch Chir. 1987. PMID: 3431277 German.

8

Kidney biopsy results versus clinical parameters on mortality and ESRD progression in 2687 patients with glomerulonephritis.

Haider DG, Masghati S, Goliasch G, Mouhieddine M, Wolzt M, Fuhrmann V, Hörl WH, Kaider A, Soleiman A. Haider DG, et al. Among authors: horl wh. Eur J Clin Invest. 2014 Jun;44(6):578-86. doi: 10.1111/eci.12274. Eur J Clin Invest. 2014. PMID: 24749685

9

Prospective multicenter study of HX575 (biosimilar epoetin-α) in patients with chronic kidney disease applying a target hemoglobin of 10--12 g/dl.

Hörl WH, Locatelli F, Haag-Weber M, Ode M, Roth K; Epo-PASS study group. Hörl WH, et al. Clin Nephrol. 2012 Jul;78(1):24-32. doi: 10.5414/cn107440. Clin Nephrol. 2012. PMID: 22732334 Clinical Trial.

10

Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade.

Kleinert J, Lorenz M, Köstler W, Hörl W, Sunder-Plassmann G, Soleiman A. Kleinert J, et al. Wien Klin Wochenschr. 2004 May 31;116(9-10):334-8. doi: 10.1007/BF03040906. Wien Klin Wochenschr. 2004. PMID: 15237661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results